-
Famed cartoonist Chappatte calls medium a 'barometer' of freedom
-
Three things we learned from the Miami Grand Prix
-
Energy crisis fuels calls to cut methane emissions
-
Europe, Canada pull together in Yerevan in Trump's shadow
-
India's Modi eyes important win in opposition-held West Bengal
-
Hantavirus: spread by rodents, potentially fatal, with no specific cure
-
French starlet Seixas to ride Tour de France in July
-
Cruise ship operator says Dutch to repatriate two ill passengers
-
India's Modi eyes win in opposition-held West Bengal
-
In Wales, UK Labour Party loses grip on storied heartland
-
Musk vs OpenAI trial enters second week
-
India's Modi faces key test as vote count underway
-
Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
-
Badminton no.1 An brings 'fire' as South Korea win Uber Cup
-
Saka sparks Arsenal attack into life ahead of Atletico showdown
-
Atletico aim to show Alvarez their ambition in Arsenal semi
-
Seoul, Taipei hit records as Asian stocks track Wall St tech rally
-
Boeing faces civil trial over 737 MAX crash
-
Australian inquiry opens public hearings into Bondi Beach shooting
-
Iran warns of ceasefire violation as US plans to escort Hormuz ships
-
North Korean club to play rare football match in South
-
Pistons rout Magic to cap comeback, book NBA playoff clash with Cavaliers
-
Japan, Australia discuss energy, critical minerals
-
Village braces for closure of Spain's largest nuclear plant
-
GameStop makes $56 billion takeover bid for eBay
-
Ex-NY mayor Giuliani hospitalized in 'critical' condition: spokesman
-
Europe, Canada leaders hold Yerevan talks in Trump's shadow
-
'No pilgrims': regional war hushes Iraq's holy cities
-
Israel court extends detention of two Gaza flotilla activists
-
Massive search continues for two missing US soldiers in Morocco
-
Players keep up battle with tennis majors as they decry Roland Garros prize money
-
Inn-Flow Acquires Lilo to Unify Procurement with Accounting and Labor, Accelerating AI-Driven Innovation Across Its Hotel Platform
-
Advanced Chiropractic Equipment & Seminars Announces Venue Change for May 2026 Postgraduate Seminar in Houston
-
Elektros Inc. Announces Strategic Lithium Expansion and Proprietary EV Charging Breakthrough Positioned for Long-Term Shareholder Value Creation
-
a.i. solutions Achieves CMMC Level 2 Certification
-
Silver Spruce Resources Announces Resumption of Exploration at its Melchett Lake Au-Ag-Zn-Pb-Cu Volcanogenic Massive Sulphide Project, Nakina, Ontario
-
Xcelerate Announces Agreements with Tanzanian Medical Professionals
-
American Vanguard Announces Date of First Quarter 2026 Earnings Release and Webcast Conference Call
-
Shelfie Signs Definitive Agreement to Acquire Majority Interest in Israeli Based Aspect Information Systems Ltd.
-
Graber Introduces a Smarter, Softer Approach to Window Design for Spring 2026
-
Greenland Mines (NASDAQ:GRML) Signs 12-Part Featured Series on New to The Street
-
LINGA Launches LINGA Kiosk to Elevate Self-Service Experiences in Hospitality
-
Alfredo Lewis Launches QOAT, Introducing a New Category in Professional Color Care Built Around Color Preservation, Co-founded with Aditi Sharma and Available at SalonCentric
-
RedChip Companies Announces Silver Sponsorship of the 16th Annual LD Micro Invitational
-
American College of Education Donates $4,500 in Gifts to Teachers' Treasures for Teacher Appreciation Week
-
Borussia Dortmund Publishes Preliminary Figures for the Third Quarter (Q3) of the 2025/2026 Financial Year
-
Worksport (NASDAQ:WKSP) Invited to Present at D. Boral 2026 Global Conference
-
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
-
NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
-
AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape
TailorMed and Flatiron Health Partner to Expand Medication Access and Support Across Oncology Care
Collaboration brings end-to-end medication support to Flatiron's network, helping community oncology practices connect patients to the resources they need to start and stay on therapy
NEW YORK, NY / ACCESS Newswire / May 4, 2026 / TailorMed, the leading medication success platform, today announced a new partnership with Flatiron Health to offer access to comprehensive medication support across Flatiron's network of oncology providers. Through this collaboration, TailorMed becomes part of the Flatiron Vendor Network, enabling practices to more easily connect patients to financial assistance, support programs, and adherence resources throughout the medication journey.
TailorMed's end-to-end platform integrates into existing workflows to proactively identify patients at risk, match them to available resources, and streamline enrollment, helping care teams reduce delays and improve patient outcomes without adding complexity.
"Access and affordability remain some of the biggest barriers in oncology care," said Srulik Dvorsky, CEO of TailorMed. "By partnering with Flatiron, we're able to extend that support directly into the workflows that providers already rely on, helping more patients to get the therapy they need and stay on it."
"Flatiron is building connected, clinically informed technology that helps providers deliver better care, faster," said Quincy Weatherspoon, Vice President & GM, Flatiron Point of Care Solutions at Flatiron Health. "Our partnership with TailorMed expands the resources available across our OncoEMR network, helping providers navigate financial barriers and ensure more patients can access and stay on the therapies they need."
TailorMed supports the full lifecycle of medication access, combining enterprise workflow tools with patient-facing solutions such as a virtual copay wallet and resource hub. As part of Flatiron's vendor network, this approach brings greater visibility and coordination to a historically fragmented process, helping ensure support reaches patients wherever care happens.
About TailorMed
TailorMed is the medication success platform removing every barrier across the patient medication journey, from access and affordability through adherence and ongoing care. Through a connected network spanning 945+ hospitals, 4,700+ clinics, 3,100+ pharmacies, 100+ life sciences programs, and 6,000+ support programs, TailorMed has supported over 75 million patients and secured more than $7.4 billion in financial assistance since 2020. TailorMed's platform, including TailorMed Core, TailorMed Connect, TailorMed Complete, TailorMed Amplify, and TailorMed Alliance, connects patients, providers, pharmacies, and life sciences companies through one coordinated network designed to reach every patient at every step of their medication journey. Learn more at tailormed.com
About Flatiron
Flatiron Health is a healthtech company expanding the possibilities for point-of-care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
PR Contact:
Jen Martin
[email protected]
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
[email protected]
Flatiron Health Media Contact:
Nina Toor
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
B.Finley--AMWN